Does Statin Usage Reduce the Risk of Corticosteroid-Related Osteonecrosis in Renal Transplant Population?

Orthopedic Clinics of North America

Volumn 40, Issue 2, 2009, Pages 235-239

  Ajmal, Muhammad ^a   Matas, A J ^b   Kuskowski, Michael ^a   Cheng, Edward Y ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Avascular necrosis; Incidence; Osteonecrosis; Statins; Transplant

Indexed keywords

ATORVASTATIN; CERIVASTATIN; CORTICOSTEROID; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOVASTATIN PLUS NICOTINIC ACID; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADOLESCENT; AGED; BONE NECROSIS; CHOLESTEROL METABOLISM; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG USE; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SEX DIFFERENCE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; CHOLESTEROL; DISEASE-FREE SURVIVAL; FEMALE; FEMUR HEAD NECROSIS; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 63549089026     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ocl.2009.01.004     Document Type: Review

References (32)

1. Harrington K.D., Murray W.R., Kountz S.L., et al. Avascular necrosis of bone after renal transplantation. J Bone Joint Surg Am 53 2 (1971) 203-215
2. Ibels L.S., Alfrey A.C., Huffer W.E., et al. Aseptic necrosis of bone following renal transplantation: experience in 194 transplant recipients and review of the literature. Medicine (Baltimore) 57 1 (1978) 25-45
3. Julian B.A., Quarles L.D., and Niemann K.M. Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis 19 2 (1992) 99-120
4. Carvalho A.C., Lees R.S., Vaillancourt R.A., et al. Intravascular coagulation in hyperlipidemia. Thromb Res 8 6 (1976) 843-857
5. Jones Jr. J.P. Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop Relat Res 292 (1993) 294-308
6. Saito S., Ohzono K., and Ono K. Early arteriopathy and postulated pathogenesis of osteonecrosis of the femoral head. The intracapital arterioles. Clin Orthop Relat Res 277 (1992) 98-110
7. Hedri H., Cherif M., Zouaghi K., et al. Avascular osteonecrosis after renal transplantation. Transplant Proc 39 4 (2007) 1036-1038
8. Le Parc J.M., Andre T., Helenon O., et al. Osteonecrosis of the hip in renal transplant recipients. Changes in functional status and magnetic resonance imaging findings over three years in three hundred five patients. Rev Rhum Engl Ed 63 6 (1996) 413-420
9. Marston S.B., Gillingham K., Bailey R.F., et al. Osteonecrosis of the femoral head after solid organ transplantation: a prospective study. J Bone Joint Surg Am 84-A 12 (2002) 2145-2151
10. Arlet J. Nontraumatic avascular necrosis of the femoral head. Past, present, and future. Clin Orthop Relat Res 277 (1992) 12-21
11. Cruess R.L. Osteonecrosis of bone. Current concepts as to etiology and pathogenesis. Clin Orthop Relat Res 208 (1986) 30-39
12. Mont M.A., and Hungerford D.S. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 77 3 (1995) 459-474
13. Cui Q., Wang G.J., and Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg Am 79 7 (1997) 1054-1063
14. Cui Q., Wang G.J., Su C.C., et al. The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res 344 (1997) 8-19
15. Li X., Jin L., Cui Q., et al. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 16 1 (2005) 101-108
16. Li X., Cui Q., Kao C., et al. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33 4 (2003) 652-659
17. Pritchett J.W. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res 386 (2001) 173-178
18. Wang G.J., Cui Q., and Balian G. The Nicolas Andry Award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res 370 (2000) 295-310
19. Humar A., Johnson E.M., Gillingham K.J., et al. Venous thromboembolic complications after kidney and kidney-pancreas transplantation: a multivariate analysis. Transplantation 65 2 (1998) 229-234
20. Almond P.S., Matas A., Gillingham K., et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 55 4 (1993) 752-756 [discussion: 756-7]
21. Cox D. The analysis of exponentially distributed life-times with two types of failures. J R Stat Soc 21 series B (1959) 411-421
22. Kaplan E.L., and Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 53 (1958) 457-481
23. Maritz F.J., Conradie M.M., Hulley P.A., et al. Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler Thromb Vasc Biol 21 10 (2001) 1636-1641
24. Jacobs B. Epidemiology of traumatic and nontraumatic osteonecrosis. Clin Orthop Relat Res 130 (1978) 51-67
25. Ono K., Tohjima T., and Komazawa T. Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy. Clin Orthop Relat Res 277 (1992) 89-97
26. Zizic T.M., Marcoux C., Hungerford D.S., et al. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med 79 5 (1985) 596-604
27. Lima J.J., Mauras N., Kissoon N., et al. Influence of sex and beta2 adrenergic receptor haplotype on resting and terbutaline-stimulated whole body lipolysis. Metabolism 54 4 (2005) 492-499
28. Mittendorfer B. Sexual dimorphism in human lipid metabolism. J Nutr 135 4 (2005) 681-686
29. Fordyce M.J., and Solomon L. Early detection of avascular necrosis of the femoral head by MRI. J Bone Joint Surg Br 75 3 (1993) 365-367
30. Mulliken B.D., Renfrew D.L., Brand R.A., et al. Prevalence of previously undetected osteonecrosis of the femoral head in renal transplant recipients. Radiology 192 3 (1994) 831-834
31. Tervonen O., Mueller D.M., Matteson E.L., et al. Clinically occult avascular necrosis of the hip: prevalence in an asymptomatic population at risk. Radiology 182 3 (1992) 845-847
32. Cheng E.Y., Thongtrangan I., Laorr A., et al. Spontaneous resolution of osteonecrosis of the femoral head. J Bone Joint Surg Am 86-A 12 (2004) 2594-2599